Bavarian Nordic to Present at Jefferies 2016 Healthcare Conference in New York
(Thomson Reuters ONE) -
COPENHAGEN, Denmark - June 2, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC:
BVNRY) announced today that Paul Chaplin, President & Chief Executive Officer
will provide a corporate presentation at the Jefferies 2016 Healthcare
Conference in New York on Wednesday, June 8, 2016 at 10:30 a.m. ET.
A live and archived webcast of the presentation will be available at
http://bit.ly/20VhF9K.
About Bavarian Nordic
Bavarian Nordic is a fully integrated biotechnology company focused on the
development, manufacturing and commercialization of cancer immunotherapies and
vaccines for infectious diseases, based on the Company's live virus vaccine
platform. Through long-standing collaborations, including a collaboration with
the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for
infectious diseases, including the non-replicating smallpox vaccine,
IMVAMUNE(®), which is stockpiled for emergency use by the United States and
other governments. The vaccine is approved in the European Union (under the
trade name IMVANEX(®)) and in Canada. Bavarian Nordic and its partner Janssen
are developing an Ebola vaccine regimen, which has been fast-tracked, with the
backing of worldwide health authorities, and a vaccine for the prevention and
treatment of HPV. Additionally, in collaboration with the National Cancer
Institute, Bavarian Nordic has developed a portfolio of active cancer
immunotherapies, including PROSTVAC(®), which is currently in Phase 3 clinical
development for the treatment of advanced prostate cancer. The company has
partnered with Bristol-Myers Squibb for the potential commercialization of
PROSTVAC. For more information visit www.bavarian-nordic.com or follow us on
Twitter (at)bavariannordic.
Contacts
U.S.: Seth Lewis, Vice President, Investor Relations & Communications. Phone: +
1 978 341 5271
Europe: Rolf Sass Sørensen, Vice President Investor Relations & Communications.
Phone +45 61 77 47 43
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via GlobeNewswire
[HUG#2017600]
Unternehmensinformation / Kurzprofil:
Datum: 02.06.2016 - 17:30 Uhr
Sprache: Deutsch
News-ID 475430
Anzahl Zeichen: 2683
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 296 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic to Present at Jefferies 2016 Healthcare Conference in New York"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
